🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Dual Diagnosis

Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage NCT05939167Phase 1, Phase 24 sites📍 Beijing📍 Beijing📍 Shenzhen Cell Energy Life Sciences Group Co. LTD · Tests: mesenchymal stem cell, saline Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound NCT07357571n/a2 sites📍 Guangdong📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema) NCT07355075Phase 2, Phase 31 site📍 Irving Turn Therapeutics · Tests: GX-03, Vehicle The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation NCT06843551Phase 21 site📍 Miami Benjamin Spieler · Tests: Stereotactic Body Radiation Therapy, Botensilimab, Balstilimab Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress NCT03642028Phase 44 sites📍 Long Beach📍 San Francisco📍 Salisbury VA Office of Research and Development · Tests: Suvorexant, Placebo Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) NCT05407987Phase 31 site📍 Calgary AHS Cancer Control Alberta · Tests: Ferric derisomaltose, Placebo A Study of SHR-2173 in Participants With Primary IgA Nephropathy NCT07354932Phase 22 sites📍 Guangzhou📍 Shanghai Guangdong Hengrui Pharmaceutical Co., Ltd · Tests: SHR-2173 injection, SHR-2173 injection, SHR-2173 injection, Placebo Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD) NCT07086521Phase 11 site📍 Palo Alto Restem, LLC. · Tests: ULSC, Placebo Conditioning Electrical Stimulation to Improve Outcomes in Cubital Tunnel Syndrome NCT05395715NA1 site📍 Edmonton University of Alberta · Tests: Electrical stimulation Platelet-Rich Plasma for Peyronie's Disease NCT07117955NA1 site📍 Herlev Herlev Hospital · Tests: Autologous Platelet Rich Plasma, Saline solution Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's Disease NCT07294885NA1 site📍 Shenyang General Hospital of Shenyang Military Region · Tests: deep cervical lymphaticovenous anastomosis A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors) NCT07137598Phase 265 sites📍 Avondale📍 Peoria📍 La Jolla Hoffmann-La Roche · Tests: Afimkibart, Placebo Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer. NCT05378204NA25 sites📍 Bordeaux📍 Caen📍 Clermont-Ferrand Institut Claudius Regaud · Tests: Main study:, Sub-study: Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET NCT03859921Phase 31 site📍 Hong Kong The University of Hong Kong · Tests: Dydrogesterone, Placebo Effects of Vestibular-Oriented Balance Training Versus Motor Dual Task Training on Balance, Postural Control, and Fall Risk in Chronic Stroke Survivors NCT07754747NA1 site📍 Rawalpindi Ibadat International University, Islamabad · Tests: Experimental, Control Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure NCT04445285Phase 21 site📍 Mobile Jon Simmons · Tests: Pulmozyme/ Recombinant human deoxyribonuclease (rh-DNase), 0.9%sodium chloride Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment NCT07133438Phase 41 site📍 Chongqing First Affiliated Hospital of Chongqing Medical University · Tests: Anti-VEGF drug, Mecobalamin 5 MG, Placebo Subdermal Implant-bioabsorbable Oxandrolone Pellet For Rehabilitation Following Anterior Cruciate Ligament (ACL) Surgical Reconstruction NCT06974526Phase 26 sites📍 Fortaleza📍 Belo Horizonte📍 Curitiba Science Valley Research Institute · Tests: Oxandrolone, Placebo Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity NCT07657676Phase 41 site📍 Beijing China National Center for Cardiovascular Diseases · Tests: Mazdutide, Placebo Bumetanide in Patients With Alzheimer's Disease NCT06052163Phase 21 site📍 Stanford Stanford University · Tests: Bumetanide, Placebo A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms NCT06849258NA20 sites📍 Bakersfield📍 Beverly Hills📍 La Mesa Rivermark Medical · Tests: FloStent, Sham (Control) Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I) NCT03684278Phase 214 sites📍 Aberdeen📍 Cardiff📍 Truro University of Liverpool · Tests: Infusion of 5 mg/kg Infliximab, Infusion of 10 mg/kg Infliximab, 0.9% Sodium Chloride (Placebo) Janus II Feasibility NCT06556693NA4 sites📍 Scottsdale📍 Wyoming📍 Columbus Zoll Medical Corporation · Tests: Dual Channel Stimulation Efficacy of EXPAREL vs. Bupivacaine NCT07212114Phase 31 site📍 Atlanta Emory University · Tests: EXPAREL, 0.25% bupivacaine (HCl): 50 ml, 0.25% bupivacaine (HCl): 30 ml Virtual Reality (VR-GINSO) as an Complement to Intervention for Alcohol and Cannabis Use in Youth in Residential Care NCT07834606NA1 site📍 Pozuelo de Alarcón Universidad Francisco de Vitoria · Tests: Virtual Reality, Treatment as Usual (TAU) Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis NCT06225752Phase 31 site📍 Wuhu First Affiliated Hospital of Wannan Medical College · Tests: Probucol, Placebo probucol Daridorexant for Alzheimer Disease Prevention NCT07213349Phase 21 site📍 Montreal Douglas Mental Health University Institute · Tests: Daridorexant 50 mg, Placebo Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC NCT07500220Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: EB-G3B7-NK dual-target CAR-NK cells, Fludarabine, Cyclophosphamide Suvorexant for Treatment of AUD and PTSD NCT06679062Phase 22 sites📍 Los Angeles📍 Houston Pharmacotherapies for Alcohol and Substance Use Disorders A… · Tests: Suvorexant, Placebo Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease NCT07536542NA1 site📍 Ankara Ankara University · Tests: Dual-Task Training
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy